• +1 513 549 5911 (U.S.)
  • +44 203 318 2846 (U.K.)

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports

Neurological Disorder Drugs Market

Global Neurological Disorder Drugs Market Analysis 2015-2019 and Forecast 2020-2025


Covid-19

COVID-19

Understand the influence of COVID-19 on the Neurological Disorder Drugs Market with our analysts monitoring the situation across the globe.
Snapshot
The global Neurological Disorder Drugs market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Neurological Disorder Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
        Antipsychotic
        Hypnotic & Sedative
        Analgesics
        Anticoagulants
        Others
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
        Novartis AG
        GlaxoSmithKline plc
        Merck & Co.
        Bayer AG
        AstraZeneca
        Boehringer Ingelheim GmbH
        Teva Pharmaceutical Industries Ltd
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
        Hospital
        Clinic
        Home
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
        North America (U.S., Canada, Mexico)
        Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
        Asia-Pacific (China, India, Japan, Southeast Asia etc.)
        South America (Brazil, Argentina etc.)
        Middle East & Africa (Saudi Arabia, South Africa etc.)	
Table of Content

1 Industry Overview
    1.1 Neurological Disorder Drugs Industry
                Figure Neurological Disorder Drugs Industry Chain Structure
        1.1.1 Overview
        1.1.2 Development of Neurological Disorder Drugs
    1.2 Market Segment
        1.2.1 Upstream
                Table Upstream Segment of Neurological Disorder Drugs
        1.2.2 Downstream
                Table Application Segment of Neurological Disorder Drugs
                Table Global Neurological Disorder Drugs Market 2015-2025, by Application, in USD Million
    1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
    2.1 Policy
    2.2 Economics
    2.3 Sociology
    2.4 Technology
3 Neurological Disorder Drugs Market by Type
    3.1 By Type
        3.1.1 Antipsychotic
                Table Major Company List of Antipsychotic
        3.1.2 Hypnotic & Sedative
                Table Major Company List of Hypnotic & Sedative
        3.1.3 Analgesics
                Table Major Company List of Analgesics
        3.1.4 Anticoagulants
                Table Major Company List of Anticoagulants
        3.1.5 Others
                Table Major Company List of Others
    3.2 Market Size
                Table Global Neurological Disorder Drugs Market 2015-2019, by Type, in USD Million
                Figure Global Neurological Disorder Drugs Market Growth 2015-2019, by Type, in USD Million
                Table Global Neurological Disorder Drugs Market 2015-2019, by Type, in Volume
                Figure Global Neurological Disorder Drugs Market Growth 2015-2019, by Type, in Volume
    3.3 Market Forecast
                Table Global Neurological Disorder Drugs Market Forecast 2020-2025, by Type, in USD Million
                Table Global Neurological Disorder Drugs Market Forecast 2020-2025, by Type, in Volume
4 Major Companies List
    4.1 Novartis AG (Company Profile, Sales Data etc.)
        4.1.1 Novartis AG Profile
                Table Novartis AG Overview List
        4.1.2 Novartis AG Products & Services
        4.1.3 Novartis AG Business Operation Conditions
                Table Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.2 GlaxoSmithKline plc (Company Profile, Sales Data etc.)
        4.2.1 GlaxoSmithKline plc Profile
                Table GlaxoSmithKline plc Overview List
        4.2.2 GlaxoSmithKline plc Products & Services
        4.2.3 GlaxoSmithKline plc Business Operation Conditions
                Table Business Operation of GlaxoSmithKline plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.3 Merck & Co. (Company Profile, Sales Data etc.)
        4.3.1 Merck & Co. Profile
                Table Merck & Co. Overview List
        4.3.2 Merck & Co. Products & Services
        4.3.3 Merck & Co. Business Operation Conditions
                Table Business Operation of Merck & Co. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.4 Bayer AG (Company Profile, Sales Data etc.)
        4.4.1 Bayer AG Profile
                Table Bayer AG Overview List
        4.4.2 Bayer AG Products & Services
        4.4.3 Bayer AG Business Operation Conditions
                Table Business Operation of Bayer AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.5 AstraZeneca (Company Profile, Sales Data etc.)
        4.5.1 AstraZeneca Profile
                Table AstraZeneca Overview List
        4.5.2 AstraZeneca Products & Services
        4.5.3 AstraZeneca Business Operation Conditions
                Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.6 Boehringer Ingelheim GmbH (Company Profile, Sales Data etc.)
        4.6.1 Boehringer Ingelheim GmbH Profile
                Table Boehringer Ingelheim GmbH Overview List
        4.6.2 Boehringer Ingelheim GmbH Products & Services
        4.6.3 Boehringer Ingelheim GmbH Business Operation Conditions
                Table Business Operation of Boehringer Ingelheim GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
    4.7 Teva Pharmaceutical Industries Ltd (Company Profile, Sales Data etc.)
        4.7.1 Teva Pharmaceutical Industries Ltd Profile
                Table Teva Pharmaceutical Industries Ltd Overview List
        4.7.2 Teva Pharmaceutical Industries Ltd Products & Services
        4.7.3 Teva Pharmaceutical Industries Ltd Business Operation Conditions
                Table Business Operation of Teva Pharmaceutical Industries Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
    5.1 Company Competition
                Table Global Neurological Disorder Drugs Sales Revenue 2015-2019, by Company, in USD Million
                Table Global Neurological Disorder Drugs Sales Revenue Share 2015-2019, by Company, in USD Million
                Figure Global Neurological Disorder Drugs Sales Revenue Share in 2019, by Company, in USD Million
                Table Global Neurological Disorder Drugs Sales Volume 2015-2019, by Company, in Volume
                Table Global Neurological Disorder Drugs Sales Volume Share 2015-2019, by Company, in Volume
                Figure Global Neurological Disorder Drugs Sales Volume Share in 2019, by Company, in Volume
    5.2 Regional Market by Company
                Figure North America Neurological Disorder Drugs Market Concentration, in 2019
                Figure Europe Neurological Disorder Drugs Market Market Concentration, in 2019
                Figure Asia-Pacific Neurological Disorder Drugs MMarket Concentration, in 2019
                Figure South America Neurological Disorder Drugs Market Concentration, in 2019
                Figure Middle East & Africa Neurological Disorder Drugs Market Concentration, in 2019
6 Demand by End Market
    6.1 Demand Situation
        6.1.1 Demand in Hospital
                Figure Neurological Disorder Drugs Demand in Hospital, 2015-2019, in USD Million
                Figure Neurological Disorder Drugs Demand in Hospital, 2015-2019, in Volume
        6.1.2 Demand in Clinic
                Figure Neurological Disorder Drugs Demand in Clinic, 2015-2019, in USD Million
                Figure Neurological Disorder Drugs Demand in Clinic, 2015-2019, in Volume
        6.1.3 Demand in Home
                Figure Neurological Disorder Drugs Demand in Home, 2015-2019, in USD Million
                Figure Neurological Disorder Drugs Demand in Home, 2015-2019, in Volume
    6.2 Regional Demand Comparison
                Table Regional Demand Comparison List
                Table Major Application in Different Regions
    6.3 Demand Forecast
                Table Neurological Disorder Drugs Demand Forecast 2020-2025, by Application, in USD Million
                Figure Neurological Disorder Drugs Market Growth 2020-2025, by Application, in USD Million
                Figure Neurological Disorder Drugs Market Share in 2025, by Application, in USD Million
                Table Neurological Disorder Drugs Demand Forecast 2020-2025, by Application, in Volume
                Table Neurological Disorder Drugs Market Growth 2020-2025, by Application, in Volume
                Table Neurological Disorder Drugs Market Share in 2025, by Application, in Volume
7 Region Operation
    7.1 Regional Production
                Table Neurological Disorder Drugs Production 2015-2019, by Region, in USD Million
                Table Neurological Disorder Drugs Production 2015-2019, by Region, in Volume
    7.2 Regional Market
                Table Global Neurological Disorder Drugs Market 2015-2019, by Region, in USD Million
                Table Global Neurological Disorder Drugs Market Share 2015-2019, by Region, in USD Million
                Table Global Neurological Disorder Drugs Market 2015-2019, by Region, in Volume
                Table Global Neurological Disorder Drugs Market Share 2015-2019, by Region, in Volume
    7.3 by Region
        7.3.1 North America
            7.3.1.1 Overview
                Figure North America Neurological Disorder Drugs Market Size and Growth 2015-2019, in USD Million
                Figure North America Neurological Disorder Drugs Market Size and Growth 2015-2019, in Volume
            7.3.1.2 by Country (U.S., Canada, Mexico)
                Table North America Neurological Disorder Drugs Market Size 2015-2019, by Country, in USD Million
                Table North America Neurological Disorder Drugs Market Size 2015-2019, by Country, in Volume
        7.3.2 Europe
            7.3.2.1 Overview
                Figure Europe Neurological Disorder Drugs Market Size and Growth 2015-2019, in USD Million
                Figure Europe Neurological Disorder Drugs Market Size and Growth 2015-2019, in Volume
            7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
                Table Europe Neurological Disorder Drugs Market Size 2015-2019, by Country, in USD Million
                Table Europe Neurological Disorder Drugs Market Size 2015-2019, by Country, in Volume
        7.3.3 Asia-Pacific
            7.3.3.1 Overview
                Figure Asia-Pacific Neurological Disorder Drugs Market Size and Growth 2015-2019, in USD Million
                Figure Asia-Pacific Neurological Disorder Drugs Market Size and Growth 2015-2019, in Volume
            7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
                Table Asia-Pacific Neurological Disorder Drugs Market Size 2015-2019, by Country, in USD Million
                Table Asia-Pacific Neurological Disorder Drugs Market Size 2015-2019, by Country, in Volume
        7.3.4 South America
            7.3.4.1 Overview
                Figure South America Neurological Disorder Drugs Market Size and Growth 2015-2019, in USD Million
                Figure South America Neurological Disorder Drugs Market Size and Growth 2015-2019, in Volume
            7.3.4.2 by Country (Brazil, Argentina etc.)
                Table South America Neurological Disorder Drugs Market Size 2015-2019, by Country, in USD Million
                Table South America Neurological Disorder Drugs Market Size 2015-2019, by Country, in Volume
        7.3.5 Middle East & Africa
            7.3.5.1 Overview
                Figure Middle East & Africa Neurological Disorder Drugs Market Size and Growth 2015-2019, in USD Million
                Figure Middle East & Africa Neurological Disorder Drugs Market Size and Growth 2015-2019, in Volume
            7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
                Table Middle East & Africa Neurological Disorder Drugs Market Size 2015-2019, by Country, in USD Million
                Table Middle East & Africa Neurological Disorder Drugs Market Size 2015-2019, by Country, in Volume
    7.4 Regional Import & Export
    7.5 Regional Forecast
                Table Neurological Disorder Drugs Market Forecast 2020-2025, by Region, in USD Million
                Table Neurological Disorder Drugs Market Forecast 2020-2025, by Region, in Volume
8 Marketing & Price
    8.1 Price and Margin
        8.1.1 Price Trends
        8.1.2 Factors of Price Change
                Table Price Factors List
        8.1.3 Manufacturers Gross Margin Analysis
    8.2 Marketing Channel
                Figure Marketing Channels Overview
9 Research Conclusion

	Table Upstream Segment of Neurological Disorder Drugs
                Table Application Segment of Neurological Disorder Drugs
                Table Global Neurological Disorder Drugs Market 2015-2025, by Application, in USD Million
                Table Major Company List of Hypnotic & Sedative
                Table Major Company List of Analgesics
                Table Major Company List of Anticoagulants
                Table Major Company List of Others
                Table Global Neurological Disorder Drugs Market 2015-2019, by Type, in USD Million
                Table Global Neurological Disorder Drugs Market 2015-2019, by Type, in Volume
                Table Global Neurological Disorder Drugs Market Forecast 2020-2025, by Type, in USD Million
                Table Global Neurological Disorder Drugs Market Forecast 2020-2025, by Type, in Volume
                Table Novartis AG Overview List
                Table Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
                Table GlaxoSmithKline plc Overview List
                Table Business Operation of GlaxoSmithKline plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
                Table Merck & Co. Overview List
                Table Business Operation of Merck & Co. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
                Table Bayer AG Overview List
                Table Business Operation of Bayer AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
                Table AstraZeneca Overview List
                Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
                Table Boehringer Ingelheim GmbH Overview List
                Table Business Operation of Boehringer Ingelheim GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
                Table Teva Pharmaceutical Industries Ltd Overview List
                Table Business Operation of Teva Pharmaceutical Industries Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
                Table Global Neurological Disorder Drugs Sales Revenue 2015-2019, by Company, in USD Million
                Table Global Neurological Disorder Drugs Sales Revenue Share 2015-2019, by Company, in USD Million
                Table Global Neurological Disorder Drugs Sales Volume 2015-2019, by Company, in Volume
                Table Global Neurological Disorder Drugs Sales Volume Share 2015-2019, by Company, in Volume
                Table Regional Demand Comparison List
                Table Major Application in Different Regions
                Table Neurological Disorder Drugs Demand Forecast 2020-2025, by Application, in USD Million
                Table Neurological Disorder Drugs Demand Forecast 2020-2025, by Application, in Volume
                Table Neurological Disorder Drugs Market Growth 2020-2025, by Application, in Volume
                Table Neurological Disorder Drugs Market Share in 2025, by Application, in Volume
                Table Neurological Disorder Drugs Production 2015-2019, by Region, in USD Million
                Table Neurological Disorder Drugs Production 2015-2019, by Region, in Volume
                Table Global Neurological Disorder Drugs Market 2015-2019, by Region, in USD Million
                Table Global Neurological Disorder Drugs Market Share 2015-2019, by Region, in USD Million
                Table Global Neurological Disorder Drugs Market 2015-2019, by Region, in Volume
                Table Global Neurological Disorder Drugs Market Share 2015-2019, by Region, in Volume
                Table North America Neurological Disorder Drugs Market Size 2015-2019, by Country, in USD Million
                Table North America Neurological Disorder Drugs Market Size 2015-2019, by Country, in Volume
                Table Europe Neurological Disorder Drugs Market Size 2015-2019, by Country, in USD Million
                Table Europe Neurological Disorder Drugs Market Size 2015-2019, by Country, in Volume
                Table Asia-Pacific Neurological Disorder Drugs Market Size 2015-2019, by Country, in USD Million
                Table Asia-Pacific Neurological Disorder Drugs Market Size 2015-2019, by Country, in Volume
                Table South America Neurological Disorder Drugs Market Size 2015-2019, by Country, in USD Million
                Table South America Neurological Disorder Drugs Market Size 2015-2019, by Country, in Volume
                Table Middle East & Africa Neurological Disorder Drugs Market Size 2015-2019, by Country, in USD Million
                Table Middle East & Africa Neurological Disorder Drugs Market Size 2015-2019, by Country, in Volume
                Table Neurological Disorder Drugs Market Forecast 2020-2025, by Region, in USD Million
                Table Neurological Disorder Drugs Market Forecast 2020-2025, by Region, in Volume
                Table Price Factors List 

                Figure Neurological Disorder Drugs Industry Chain Structure
                Figure Global Neurological Disorder Drugs Market Growth 2015-2019, by Type, in USD Million
                Figure Global Neurological Disorder Drugs Market Growth 2015-2019, by Type, in Volume
                Figure Global Neurological Disorder Drugs Sales Revenue Share in 2019, by Company, in USD Million
                Figure Global Neurological Disorder Drugs Sales Volume Share in 2019, by Company, in Volume
                Figure North America Neurological Disorder Drugs Market Concentration, in 2019
                Figure Europe Neurological Disorder Drugs Market Market Concentration, in 2019
                Figure Asia-Pacific Neurological Disorder Drugs MMarket Concentration, in 2019
                Figure South America Neurological Disorder Drugs Market Concentration, in 2019
                Figure Middle East & Africa Neurological Disorder Drugs Market Concentration, in 2019
                Figure Neurological Disorder Drugs Demand in Hospital, 2015-2019, in USD Million
                Figure Neurological Disorder Drugs Demand in Hospital, 2015-2019, in Volume
                Figure Neurological Disorder Drugs Demand in Clinic, 2015-2019, in USD Million
                Figure Neurological Disorder Drugs Demand in Clinic, 2015-2019, in Volume
                Figure Neurological Disorder Drugs Demand in Home, 2015-2019, in USD Million
                Figure Neurological Disorder Drugs Demand in Home, 2015-2019, in Volume
                Figure Neurological Disorder Drugs Market Growth 2020-2025, by Application, in USD Million
                Figure Neurological Disorder Drugs Market Share in 2025, by Application, in USD Million
                Figure North America Neurological Disorder Drugs Market Size and Growth 2015-2019, in USD Million
                Figure North America Neurological Disorder Drugs Market Size and Growth 2015-2019, in Volume
                Figure Europe Neurological Disorder Drugs Market Size and Growth 2015-2019, in USD Million
                Figure Europe Neurological Disorder Drugs Market Size and Growth 2015-2019, in Volume
                Figure Asia-Pacific Neurological Disorder Drugs Market Size and Growth 2015-2019, in USD Million
                Figure Asia-Pacific Neurological Disorder Drugs Market Size and Growth 2015-2019, in Volume
                Figure South America Neurological Disorder Drugs Market Size and Growth 2015-2019, in USD Million
                Figure South America Neurological Disorder Drugs Market Size and Growth 2015-2019, in Volume
                Figure Middle East & Africa Neurological Disorder Drugs Market Size and Growth 2015-2019, in USD Million
                Figure Middle East & Africa Neurological Disorder Drugs Market Size and Growth 2015-2019, in Volume
                Figure Marketing Channels Overview

Related Reports

Achondroplasia-Treatment-Market

(COVID-19 Version) Global Achondroplasia Treatment Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use

Summary The report forecast global Achondroplasia Treatment market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report of ...read more

Acne-Drugs-Market

(COVID-19 Version) Global Acne Drugs Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use

Summary The report forecast global Acne Drugs market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed ...read more

Actinic-Solar-Keratosis-Treatment-Market

(COVID-19 Version) Global Actinic (Solar) Keratosis Treatment Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use

Summary The report forecast global Actinic (Solar) Keratosis Treatment market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. Th ...read more

Albendazole-Market

(COVID-19 Version) Global Albendazole Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use

Summary The report forecast global Albendazole market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed ...read more

Amlexanox-Market

(COVID-19 Version) Global Amlexanox Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use

Summary The report forecast global Amlexanox market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed c ...read more

Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.

Cards For Payment
Trusted Badge SSL Certified Premium Quality

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

How To Reach Us

Reach out to our most senior Sales Professional- Jay Matthews
   +1 513 549 5911 (US)
          +44 203 318 2846 (UK)
   sales@reportsmonitor.com

Our Clients

Samsung 3M BCG LEK Consulting McKinsey Thyssenkrupp Mogensen BASF IQVIA Hella Oracle Accenture Saint Gobain

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
--Marketing Manager at a pharma company in Belgium

Enquire Before Buying

Need to ask a quick question before buying? Please fill out this short form:

Our Features

Wide Network of Publishers

Wide Network of Publishers

Access to over 1M+ market research reports

Trusted by the Best

Trusted by the Best

50+ Clients in Fortune 500

Competitive Pricing

Competitive Pricing

Our regular promotional offers and discounts make us the most economic seller of market reports

Safe and Secure

Safe and Secure

Your payment details are protected by us.